SANTANDER UK PLC
PUBLICATION OF LISTING PROSPECTUS
The following listing prospectus
(the Prospectus) has been
approved by the UK Financial Conduct Authority and is available for
viewing:
Listing Prospectus dated 26 November
2024 (the Prospectus)
relating to Multiple Series of Equity Index Linked Notes previously
issued and outstanding under the Notes and Certificate Programme of
Santander UK plc, as listed in the table below (together, the
Notes).
|
Description
|
ISIN
|
|
Series 1136 Issue of GBP 8,930,112
Equity Index Linked Notes due 30 December 2024
|
XS1866007542
|
|
Series 1139 Issue of GBP 22,107,629
Equity Index Linked Notes due 25 February 2025
|
XS1894675914
|
|
Series 1141 Issue of GBP 4,623,772
Equity Index Linked Notes due 23 April 2025
|
XS1917956440
|
|
Series 1144 Issue of GBP 18,940,809
Equity Index Linked Notes due 10 June 2025
|
XS1939334675
|
|
Series 1149 Issue of GBP 7,525,095
Equity Index Linked Notes due 12 August 2025
|
XS1970465974
|
|
Series 1151 Issue of £6,907,632
Equity Index Linked Notes due October 2025
|
XS2005531103
|
|
Series 1155 Issue of £4,472,715
Equity Index Linked Notes due December 2025
|
XS2035095459
|
|
Series 1158 Issue of £7,027,790
Equity Index Linked Notes due January 2026
|
XS2063664275
|
|
Series 1160 £4,511,380 Equity Index
Linked Notes due March 2026
|
XS2085849870
|
|
Series 1166 Issue of GBP 4,177,216
Equity Index Linked Notes due May 2026
|
XS2101558992
|
|
Series 1170 Issue of £3,856,994
Equity Index Linked Notes due July 2026
|
XS2133252218
|
|
Series 1172 Issue of £4,635,447
Equity Index Linked Notes due July 2026
|
XS2159802359
|
|
Series 1174 Issue of GBP 30,000,000
Equity Index Linked Notes due September 2026
|
XS2186175571
|
|
Series 1176 Issue of £13,225,540
Equity Index Linked Notes due November 2026
|
XS2196322585
|
|
Series 1178 Issue of £15,636,746
Equity Index Linked Notes due December 2026
|
XS2222052719
|
|
Series 1180 Issue of £39,381,201
Equity Index Linked Notes due February 2027
|
XS2238784826
|
|
Series 1182 Issue of £1,558,439
Equity Index Linked Notes due March 2027
|
XS2262949378
|
|
Series 1184 £2,834,541 Equity Index
Linked Notes due June 2027
|
XS2294359141
|
|
Series 1186 £2,247,346 Equity Index
Linked Notes due July 2027
|
XS2326318990
|
|
Series 1188 £1,901,665 Equity Index
Linked Notes due August 2027
|
XS2352402544
|
The Prospectus has been published in
order for the Notes, which are currently admitted to trading on the
regulated market of Euronext Dublin, to be admitted to the official
list of the FCA and admitted to trading on the London Stock
Exchange's Main Market (the London
Admission). The London Admission is expected to occur on or
around 29 November 2024.
It is the Issuer's intention to
delist the Notes from the regulated market of Euronext Dublin
shortly after the London Admission becomes effective.
To view the full Prospectus please
paste the following URL into the address bar of your
browser:
http://www.rns-pdf.londonstockexchange.com/rns/7412N_1-2024-11-26.pdf
A copy of the Prospectus has been
submitted to the National Storage Mechanism and will shortly be
available for inspection at: https://data.fca.org.uk/#/nsm/nationalstoragemechanism.
The Prospectus will also be
available for viewing via:
https://www.santander.co.uk/about-santander/investor-relations/santander-uk-notes-certificates-programme
For further information, please
contact:
Structured Notes Desk
Tel: +44 (0) 20 7756 7000 or
structurednotesafm@santander.co.uk.
DISCLAIMER - INTENDED ADDRESSEES
Please note that the information
contained in the Prospectus may be addressed to and/or targeted at persons who are
residents of particular countries only (as specified in the
Prospectus) and is not intended for use and should not be relied
upon by any person outside these countries and/or to whom the offer
contained in the Prospectus is not
addressed. Prior to relying on the information contained in
the Prospectus you must ascertain from
such Prospectus whether or not you are part
of the intended addressees of the information contained
therein.
This publication of the
Prospectus does not constitute an
offer of securities for sale in the United States. The securities
described in the Prospectus have not been, and will not be,
registered under the U.S. Securities Act of 1933, as amended (the
Securities Act), or under
any relevant securities laws of any state of the United States of
America, and may not be offered or sold in the United States of
America or to, or for the benefit of, U.S. persons (as defined in
Regulation S of the Securities Act), unless the securities are
registered under the Securities Act or an exemption from the
registration requirements of the Securities Act is
available.
Your right to access this service is
conditional upon your compliance with the above
requirement.
